Massachusetts Financial Services CO Amicus Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

$303 Billion
Q3 2025

A detailed history of Massachusetts Financial Services CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 3,708,738 shares of FOLD stock, worth $33.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,708,738

Previous 3,726,468 0.48%

Holding current value

$33.5 Million

Previous $21.4 Million 36.87%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$5.84 - $8.57 $103,543 - $151,946	-17,730 Reduced 0.48%	3,708,738 $29.2 Million
Q2 2025 Aug 08, 2025	BUY	$5.64 - $8.0 $2.54 Million - $3.6 Million	450,097 Added 13.74%	3,726,468 $21.4 Million
Q1 2025 May 02, 2025	BUY	$8.16 - $9.85 $73,407 - $88,610	8,996 Added 0.28%	3,276,371 $26.7 Million
Q4 2024 Feb 12, 2025	BUY	$9.36 - $12.01 $1 Million - $1.29 Million	107,348 Added 3.4%	3,267,375 $30.8 Million
Q3 2024 Nov 12, 2024	BUY	$9.55 - $12.09 $1.33 Million - $1.69 Million	139,491 Added 4.62%	3,160,027 $33.7 Million
Q2 2024 Aug 09, 2024	BUY	$9.04 - $11.75 $3.43 Million - $4.45 Million	378,999 Added 14.35%	3,020,536 $30 Million
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $2.59 Million - $3.22 Million	226,447 Added 9.38%	2,641,537 $31.1 Million
Q4 2023 Feb 08, 2024	BUY	$9.97 - $14.52 $5.91 Million - $8.61 Million	593,131 Added 32.55%	2,415,090 $34.3 Million
Q3 2023 Nov 08, 2023	BUY	$11.78 - $13.86 $4.01 Million - $4.72 Million	340,673 Added 23.0%	1,821,959 $22.2 Million
Q2 2023 Aug 09, 2023	BUY	$10.72 - $13.3 $15.9 Million - $19.7 Million	1,481,286 New	1,481,286 $18.6 Million
Q4 2021 Feb 10, 2022	SELL	$9.82 - $12.44 $8.71 Million - $11 Million	-886,513 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$8.74 - $11.84 $3.23 Million - $4.38 Million	-370,048 Reduced 29.45%	886,513 $8.47 Million
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $31,312 - $38,538	-3,595 Reduced 0.29%	1,256,561 $12.1 Million
Q1 2021 May 13, 2021	BUY	$9.2 - $23.86 $740,342 - $1.92 Million	80,472 Added 6.82%	1,260,156 $12.5 Million
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $9.72 Million - $18 Million	-721,907 Reduced 37.96%	1,179,684 $27.2 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $297,191 - $366,359	-23,056 Reduced 1.2%	1,901,591 $26.9 Million
Q2 2020 Aug 11, 2020	BUY	$8.86 - $15.69 $1.29 Million - $2.28 Million	145,456 Added 8.18%	1,924,647 $29 Million
Q1 2020 May 14, 2020	BUY	$6.63 - $11.16 $1.42 Million - $2.39 Million	214,466 Added 13.71%	1,779,191 $16.4 Million
Q4 2019 Feb 13, 2020	BUY	$7.48 - $10.75 $1.27 Million - $1.83 Million	170,062 Added 12.19%	1,564,725 $15.2 Million
Q3 2019 Nov 05, 2019	BUY	$8.02 - $13.25 $2.12 Million - $3.49 Million	263,719 Added 23.32%	1,394,663 $11.2 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $1.24 Million - $1.62 Million	112,845 Added 11.08%	1,130,944 $14.1 Million
Q1 2019 May 13, 2019	BUY	$10.04 - $13.92 $205,990 - $285,596	20,517 Added 2.06%	1,018,099 $13.8 Million
Q4 2018 Feb 08, 2019	BUY	$8.38 - $13.44 $176,080 - $282,401	21,012 Added 2.15%	997,582 $9.56 Million
Q3 2018 Oct 25, 2018	BUY	$11.6 - $16.54 $2.32 Million - $3.31 Million	200,340 Added 25.81%	976,570 $11.8 Million
Q2 2018 Jul 30, 2018	BUY	$13.13 - $17.09 $141,922 - $184,725	10,809 Added 1.41%	776,230 $12.1 Million
Q1 2018 May 04, 2018	BUY	$13.76 - $17.12 $1.11 Million - $1.37 Million	80,306 Added 11.72%	765,421 $11.5 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $112,564 - $146,127	8,998 Added 1.33%	685,115 $9.86 Million
Q3 2017 Nov 14, 2017	SELL	$11.74 - $15.78 $3.61 Million - $4.85 Million	-307,659 Reduced 31.27%	676,117 $10.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	983,776	983,776 $9.91 Million

Others Institutions Holding FOLD

# of Institutions

307

Shares Held

332M

Call Options Held

396K

Put Options Held

249K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Amicus Therapeutics, Inc. Transaction History